Format
Items per page
Sort by

Send to:

Choose Destination

Results: 18

Cited In for PubMed (Select 9574564)

1.

Reduction of Serum ADAM17 Level Accompanied with Decreased Cytokines after Abatacept Therapy in Patients with Rheumatoid Arthritis.

Umemura M, Isozaki T, Ishii S, Seki S, Oguro N, Miura Y, Miwa Y, Nakamura M, Inagaki K, Kasama T.

Int J Biomed Sci. 2014 Dec;10(4):229-35.

2.

Genomic analysis and differential expression of HMG and S100A family in human arthritis: upregulated expression of chemokines, IL-8 and nitric oxide by HMGB1.

Amin AR, Islam AB.

DNA Cell Biol. 2014 Aug;33(8):550-65. doi: 10.1089/dna.2013.2198. Epub 2014 Jun 6.

PMID:
24905701
3.

Differences in Mammalian target of rapamycin gene expression in the peripheral blood and articular cartilages of osteoarthritic patients and disease activity.

Tchetina EV, Poole AR, Zaitseva EM, Sharapova EP, Kashevarova NG, Taskina EA, Alekseeva LI, Semyonova LA, Glukhova SI, Kuzin AN, Makarov MA, Makarov SA.

Arthritis. 2013;2013:461486. doi: 10.1155/2013/461486. Epub 2013 Jun 25.

4.

Immunopathogenesis of osteoarthritis.

Haseeb A, Haqqi TM.

Clin Immunol. 2013 Mar;146(3):185-96. doi: 10.1016/j.clim.2012.12.011. Epub 2013 Jan 6. Review.

5.

Systemic overexpression of TNFα-converting enzyme does not lead to enhanced shedding activity in vivo.

Yoda M, Kimura T, Tohmonda T, Morioka H, Matsumoto M, Okada Y, Toyama Y, Horiuchi K.

PLoS One. 2013;8(1):e54412. doi: 10.1371/journal.pone.0054412. Epub 2013 Jan 14.

6.

Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates.

Minond D, Cudic M, Bionda N, Giulianotti M, Maida L, Houghten RA, Fields GB.

J Biol Chem. 2012 Oct 19;287(43):36473-87. doi: 10.1074/jbc.M112.389114. Epub 2012 Aug 27.

7.

TACE activation by MAPK-mediated regulation of cell surface dimerization and TIMP3 association.

Xu P, Liu J, Sakaki-Yumoto M, Derynck R.

Sci Signal. 2012 May 1;5(222):ra34. doi: 10.1126/scisignal.2002689.

8.
9.

ADAM-17: the enzyme that does it all.

Gooz M.

Crit Rev Biochem Mol Biol. 2010 Apr;45(2):146-69. doi: 10.3109/10409231003628015. Review.

10.

Developments in the scientific understanding of osteoarthritis.

Abramson SB, Attur M.

Arthritis Res Ther. 2009;11(3):227. doi: 10.1186/ar2655. Epub 2009 May 19. Review.

11.

Ron receptor tyrosine kinase negatively regulates TNFalpha production in alveolar macrophages by inhibiting NF-kappaB activity and Adam17 production.

Nikolaidis NM, Gray JK, Gurusamy D, Fox W, Stuart WD, Huber N, Waltz SE.

Shock. 2010 Feb;33(2):197-204. doi: 10.1097/SHK.0b013e3181ae8155.

12.

Tumour necrosis factor-alpha processing in interstitial lung disease: a potential role for exogenous proteinase-3.

Armstrong L, Godinho SI, Uppington KM, Whittington HA, Millar AB.

Clin Exp Immunol. 2009 May;156(2):336-43. doi: 10.1111/j.1365-2249.2009.03906.x. Epub 2009 Mar 9.

13.

Regulation of mature ADAM17 by redox agents for L-selectin shedding.

Wang Y, Herrera AH, Li Y, Belani KK, Walcheck B.

J Immunol. 2009 Feb 15;182(4):2449-57. doi: 10.4049/jimmunol.0802770.

14.

Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells.

Reddy AB, Ramana KV, Srivastava S, Bhatnagar A, Srivastava SK.

Endocrinology. 2009 Jan;150(1):63-74. doi: 10.1210/en.2008-0677. Epub 2008 Sep 4.

15.

Cells of the synovium in rheumatoid arthritis. Chondrocytes.

Otero M, Goldring MB.

Arthritis Res Ther. 2007;9(5):220. Review. Erratum in: Arthritis Res Ther. 2008;10(1):401.

16.

Up regulated expression of tumour necrosis factor {alpha} converting enzyme in peripheral monocytes of patients with early systemic sclerosis.

Bohgaki T, Amasaki Y, Nishimura N, Bohgaki M, Yamashita Y, Nishio M, Sawada KI, Jodo S, Atsumi T, Koike T.

Ann Rheum Dis. 2005 Aug;64(8):1165-73.

17.

Inverse regulation of the ADAM-family members, decysin and MADDAM/ADAM19 during monocyte differentiation.

Fritsche J, Müller A, Hausmann M, Rogler G, Andreesen R, Kreutz M.

Immunology. 2003 Dec;110(4):450-7.

18.

Tumour necrosis factor alpha converting enzyme (TACE) activity in the colonic mucosa of patients with inflammatory bowel disease.

Brynskov J, Foegh P, Pedersen G, Ellervik C, Kirkegaard T, Bingham A, Saermark T.

Gut. 2002 Jul;51(1):37-43.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk